SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-037476
Filing Date
2022-06-16
Accepted
2022-06-16 17:00:22
Documents
1
Period of Report
2022-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4044
  Complete submission text file 0001209191-22-037476.txt   5449
Mailing Address 200 ARSENAL YARDS BLVD., STE. 210 WATERTOWN MA 02472
Business Address 200 ARSENAL YARDS BLVD., STE. 210 WATERTOWN MA 02472 617-898-8824
SQZ Biotechnologies Co (Issuer) CIK: 0001604477 (see all company filings)

IRS No.: 462431115 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O PLIANT THERAPEUTICS, INC. 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Coulie Bernard (Reporting) CIK: 0001808895 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39662 | Film No.: 221021309